BTG's pulmonary embolism device work faster and at lower doses in study

LONDON (Reuters) - British pharmaceutical firm BTG said on Monday its EKOS combination therapy device for pulmonary embolism (PE) was effective using smaller drug dosages and shorter treatment periods than the current standard.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news